Perhaps you are misunderstanding what the auto-cloning technique with the ACell product is all about. The research we’re conducting is basically plucking out hair from a donor scalp area (where hairs are considered immune to genetic balding), applying the ACell products, and transplanting to an area of scalp where there is balding. We are not […]
232 search results for: cloning
Hair transplant surgery, just like any cosmetic/aesthetic surgery, is a situation in which the patient chooses to alter his/her appearance. Thus, if the patient wants to have their juvenile hairline back and there is enough donor hair available, I see no reason why a doctor cannot accommodate the request. The caveat is that even if […]
We really don’t know what to expect just yet. We are trying our best to carry out a study to find out if there is a foundation for a new way of treating hair loss. Ideally, if ACell works with plucked hairs and our clinical research shows this, then the infinite donor supply could be […]
One commenter to my post from a couple weeks ago asked about my recollection of the Jerry Cooley, M.D. presentation at the ISHRS meeting on the use of ACell and hair multiplication. The comment was: “The doc still has not addressed why in his previous post about Acell he said Dr. Cooley’s results are less […]
Last week I wrote about the ACell presentation at the recent International Society for Hair Restoration Surgery (ISHRS) meeting that may have opened the possibility for a patient’s hair to be multiplied in his or her own scalp. ACell’s MatriStem has had some early success with growing hairs that were plucked and then placed into […]
I’m actually in Boston at the International Society for Hair Restoration (ISHRS) Scientific Meeting, and wrote this on my little netbook to get you a timely response. The ACell material is reportedly derived from Porcine urinary bladder. Here’s a good, short description of ACell’s product from another conference they attended: “MatriStem® devices are a naturally […]
The following post is by UK-based physician Dr. Bessam Farjo: Written by: Dr Bessam Farjo United Kingdom I’m often asked about the ICX-TRC Cell Therapy Human Clinical Trial and whether or not it was successful. For those of you who don’t know, the trial was (in very simple terms) the development of a therapy whereby […]
I suppose the downfall could be the same for any new company in this space — financial backing. If the trials don’t go as well as expected, it may be harder to secure additional funds to keep making progress. I’m just speaking in generalities though. I do not follow Histogen’s business or science plans close […]
Dr. Pak and I (Dr. Rassman) write the bulk of the posts here, probably split almost down the middle, and we work together at NHI. Our newest contributor is Dr. Jino Kim, and he maintains the Korean version of BaldingBlog along with heading New Hair Institute in Seoul, Korea, where Dr. Pak recently visited to […]
Thanks for sending these links. Each press release speaks for itself. The Histogen press release isn’t specifically about their hair loss treatment (they have multiple products unrelated to hair loss treatment), but the Aderans Phase 2 clinical trials expansion is for hair regeneration. Once the studies have concluded, they will hopefully be published with the […]
The most recent issue of Scientific American has a wonderful review of the stem cell opportunities and updates on what is going on in an article titled “Your Inner Healers”. I will try to summarize this article for those of you who do not have access to this publication… Throughout history, researchers have wanted to […]
For those who freely read on, my position on hair loss has remained constant. There is no cure for hair loss and Propecia is certainly not a cure (though it helps treat hair loss in most men). I recently wrote about the discovery of the hair loss gene pathway you are referring to, but if […]
There are drugs in the pipeline for hair loss, but the real question is which, if any, will make it through the investigative and FDA process. It must be proven to be safe and effective at doing what the manufacturer will claim. So I suppose it is reasonable to assume (or at least hope) something […]
When word came out earlier this year that Intercytex was closing shop, I received a few emails inquiring about where their assets might wind up. Months later, the announcement has been made. And the winner is… Atlanta, GA – March 25, 2010 — Aderans Research Institute Inc. (ARI) announced it acquired key technology assets from […]
I did hear one thing about Histogen, and that related to a patent violation. I found this article via Google from a couple months ago that has some interesting news… Histogen was hit with a patent lawsuit last year by SkinMedica, though the article doesn’t say which patents are in possible violation. Following that, their […]
Page 9 of 16